WallStreetZenWallStreetZen

NASDAQ: INMD
Inmode Ltd Stock

Open Broker Account
$38.18-0.21 (-0.55%)
Updated Dec 1, 2022
INMD Price
$38.18
Fair Value Price
$39.09
Market Cap
$3.14B
52 Week Low
$20.60
52 Week High
$75.74
P/E
17.92x
P/B
6.18x
P/S
5.56x
PEG
0.2x
Dividend Yield
N/A
Revenue
$431.24M
Earnings
$176.50M
Gross Margin
83.9%
Operating Margin
44.49%
Profit Margin
40.9%
Debt to Equity
0.14
Operating Cash Flow
$177M
Beta
1.57
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

INMD Overview

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how INMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

INMD ($38.18) is undervalued by 2.32% relative to our estimate of its Fair Value price of $39.09 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
INMD ($38.18) is not significantly undervalued (2.32%) relative to our estimate of its Fair Value price of $39.09 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
INMD ($38.18) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more INMD due diligence checks available for Premium users.

Be the first to know about important INMD news, forecast changes, insider trades & much more!

INMD News

Valuation

INMD fair value

Fair Value of INMD stock based on Discounted Cash Flow (DCF)
Price
$38.18
Fair Value
$39.09
Undervalued by
2.32%
INMD ($38.18) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
INMD ($38.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
INMD ($38.18) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

INMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
17.92x
Industry
63.62x
Market
22.16x
INMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
INMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

INMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.18x
Industry
3.84x
INMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

INMD price to earnings growth (PEG)

For valuing profitable companies with growth potential
INMD is good value based... subscribe to Premium to read more.
PEG Value Valuation

INMD's financial health

Profit margin

Revenue
$121.2M
Net Income
$48.8M
Profit Margin
40.2%
INMD's Earnings (EBIT) of $191.88M... subscribe to Premium to read more.
Interest Coverage Financials
INMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$579.0M
Liabilities
$70.7M
Debt to equity
0.14
INMD's short-term assets ($563.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INMD's short-term assets ($563.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$45.6M
Investing
-$56.1M
Financing
$550.0k
INMD's operating cash flow ($177.32M)... subscribe to Premium to read more.
Debt Coverage Financials

INMD vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
INMD$3.14B-0.55%17.92x6.18x
AHCO$3.05B+1.34%34.78x1.41x
LIVN$3.01B+1.43%-31.91x2.62x
AXNX$3.51B+3.49%-43.21x6.39x
TNDM$2.74B+1.36%-40.59x6.50x

Inmode Stock FAQ

What is Inmode's quote symbol?

NASDAQ: INMD) Inmode trades on the NASDAQ under the ticker symbol INMD. Inmode stock quotes can also be displayed as NASDAQ: INMD.

If you're new to stock investing, here's how to buy Inmode stock.

What is the 52 week high and low for Inmode (NASDAQ: INMD)?

(NASDAQ: INMD) Inmode's 52-week high was $75.74, and its 52-week low was $20.60. It is currently -49.59% from its 52-week high and 85.34% from its 52-week low.

How much is Inmode stock worth today?

(NASDAQ: INMD) Inmode currently has 82,306,000 outstanding shares. With Inmode stock trading at $38.18 per share, the total value of Inmode stock (market capitalization) is $3.14B.

Inmode stock was originally listed at a price of $6.79 in Aug 8, 2019. If you had invested in Inmode stock at $6.79, your return over the last 3 years would have been 462.71%, for an annualized return of 77.87% (not including any dividends or dividend reinvestments).

How much is Inmode's stock price per share?

(NASDAQ: INMD) Inmode stock price per share is $38.18 today (as of Dec 1, 2022).

What is Inmode's Market Cap?

(NASDAQ: INMD) Inmode's market cap is $3.14B, as of Dec 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Inmode's market cap is calculated by multiplying INMD's current stock price of $38.18 by INMD's total outstanding shares of 82,306,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.